Detalles de la búsqueda
1.
Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.
Int J Cancer
; 144(9): 2330-2338, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30421459
2.
Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany.
J Clin Microbiol
; 57(1)2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30355760
3.
Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.
BMC Infect Dis
; 16(1): 672, 2016 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27835974
4.
Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples.
Cancer Med
; 9(3): 1058-1068, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31856411
5.
HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.
Am J Cancer Res
; 8(4): 715-722, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29736316
6.
Involvement of Brd4 in different steps of the papillomavirus life cycle.
Virus Res
; 231: 76-82, 2017 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27965149
7.
TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.
Am J Cancer Res
; 6(7): 1524-36, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27508094
Resultados
1 -
7
de 7
1
Próxima >
>>